These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 8892661

  • 1. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Meyer AL, Benson JM, Gienapp IE, Cox KL, Whitacre CC.
    J Immunol; 1996 Nov 01; 157(9):4230-8. PubMed ID: 8892661
    [Abstract] [Full Text] [Related]

  • 2. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH, Gienapp IE, Cox KL, Whitacre CC.
    J Immunol; 1995 Aug 01; 155(3):1599-605. PubMed ID: 7543526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
    al-Sabbagh A, Miller A, Santos LM, Weiner HL.
    Eur J Immunol; 1994 Sep 01; 24(9):2104-9. PubMed ID: 7522160
    [Abstract] [Full Text] [Related]

  • 6. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
    Chen Y, Inobe J, Weiner HL.
    J Immunol; 1995 Jul 15; 155(2):910-6. PubMed ID: 7541826
    [Abstract] [Full Text] [Related]

  • 7. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
    Santos LM, al-Sabbagh A, Londono A, Weiner HL.
    Cell Immunol; 1994 Sep 15; 157(2):439-47. PubMed ID: 7520838
    [Abstract] [Full Text] [Related]

  • 8. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY, Yang JS, Huang YM, Levi M, Link H, Xiao BG.
    Clin Immunol; 2000 Sep 15; 96(3):205-11. PubMed ID: 10964538
    [Abstract] [Full Text] [Related]

  • 9. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
    Lider O, Santos LM, Lee CS, Higgins PJ, Weiner HL.
    J Immunol; 1989 Feb 01; 142(3):748-52. PubMed ID: 2464023
    [Abstract] [Full Text] [Related]

  • 10. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein.
    Fritz RB, Chou CH, McFarlin DE.
    J Immunol; 1983 Mar 01; 130(3):1024-6. PubMed ID: 6185565
    [Abstract] [Full Text] [Related]

  • 11. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
    Samson MF, Smilek DE.
    J Immunol; 1995 Sep 01; 155(5):2737-46. PubMed ID: 7544383
    [Abstract] [Full Text] [Related]

  • 12. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D, Aharoni R, Klinger E, Kreitman R, Raymond E, Malley A, Shofti R, Sela M, Arnon R.
    Ann N Y Acad Sci; 2004 Dec 01; 1029():239-49. PubMed ID: 15681762
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA, Kamoun M, Ventura E, Rostami A.
    Exp Mol Pathol; 2000 Feb 01; 68(1):29-37. PubMed ID: 10640452
    [Abstract] [Full Text] [Related]

  • 14. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
    Goss JA, Nakafusa Y, Roland CR, Hickey WF, Flye MW.
    J Immunol; 1994 Nov 01; 153(9):3890-8. PubMed ID: 7523508
    [Abstract] [Full Text] [Related]

  • 15. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
    Higgins PJ, Weiner HL.
    J Immunol; 1988 Jan 15; 140(2):440-5. PubMed ID: 2447178
    [Abstract] [Full Text] [Related]

  • 16. Treatment of autoimmune disease by oral tolerance to autoantigens.
    Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N.
    Clin Immunol Immunopathol; 1996 Sep 15; 80(3 Pt 2):S31-9. PubMed ID: 8811061
    [Abstract] [Full Text] [Related]

  • 17. Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice.
    Jansson L, Diener P, Engström A, Olsson T, Holmdahl R.
    Eur J Immunol; 1995 Aug 15; 25(8):2195-200. PubMed ID: 7545112
    [Abstract] [Full Text] [Related]

  • 18. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
    Kim G, Kohyama K, Tanuma N, Arimito H, Matsumoto Y.
    J Immunol; 1998 Dec 15; 161(12):6993-8. PubMed ID: 9862735
    [Abstract] [Full Text] [Related]

  • 19. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
    Brod SA, Khan M.
    J Autoimmun; 1996 Feb 15; 9(1):11-20. PubMed ID: 8845048
    [Abstract] [Full Text] [Related]

  • 20. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
    Kennedy MK, Dal Canto MC, Trotter JL, Miller SD.
    J Immunol; 1988 Nov 01; 141(9):2986-93. PubMed ID: 2459237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.